Biogen and UCB reported additional Phase 3 data on dapirolizumab pegol in systemic lupus, and Biogen shared expanded clinical and real world findings for diranersen and lecanemab in early Alzheimer’s ...
Source LinkBiogen and UCB reported additional Phase 3 data on dapirolizumab pegol in systemic lupus, and Biogen shared expanded clinical and real world findings for diranersen and lecanemab in early Alzheimer’s ...
Source Link
Comments